Daniel Georges Bichet

Summary

Country: Canada

Publications

  1. ncbi [Nephrogenic diabetes insipidus]
    Daniel Georges Bichet
    Génétique des maladies rénales, Service de Nephrologie, départements de médecine et de physiologie, Centre de Recherche, Hopital du Sacre Coeur de Montreal, Universite de Montreal, Montreal Quebec, Canada
    Nephrol Ther 2:387-404. 2006
  2. doi Vasopressin receptor mutations in nephrogenic diabetes insipidus
    Daniel G Bichet
    Genetics of Renal Diseases, Groupe d Etude des Protéines, Membranaires, Montreal, Quebec, Canada
    Semin Nephrol 28:245-51. 2008
  3. doi Physiopathology of hereditary polyuric states: a molecular view of renal function
    Daniel G Bichet
    Universite de Montreal, Canada
    Swiss Med Wkly 142:w13613. 2012
  4. doi Genetics and diagnosis of central diabetes insipidus
    Daniel G Bichet
    Departments of Medicine and Physiology, University of Montreal, Hôpital du Sacré Cœur de Montréal, Quebec, Canada
    Ann Endocrinol (Paris) 73:117-27. 2012
  5. ncbi Hereditary polyuric disorders: new concepts and differential diagnosis
    Daniel G Bichet
    Groupe d Etude des Protéines Membranaires and the Université de Montréal, Research Centre and Nephrology Service, Hopital du Sacre Coeur de Montreal, Montreal, Quebec, Canada
    Semin Nephrol 26:224-33. 2006
  6. ncbi Nephrogenic diabetes insipidus
    Daniel G Bichet
    Centre de Recherche, Hôpital du Sacré Couer de Montréal, Montreal, Quebec, Canada
    Adv Chronic Kidney Dis 13:96-104. 2006
  7. ncbi [Nobel Prize for Chemistry 2003. Water channels and ionic channels]
    Daniel G Bichet
    Groupe d étude des protéines membranaires, Universite de Montreal, Service Néphrologie Génétique, Hopital du Sacre Coeur de Montreal, 5400, boulevard Gouin Ouest, Montreal, Quebec, H4J 1C5, Canada
    Med Sci (Paris) 19:1289-90. 2003
  8. doi Characterization of D150E and G196D aquaporin-2 mutations responsible for nephrogenic diabetes insipidus: importance of a mild phenotype
    Cécile Guyon
    Groupe d étude des protéines membranaires, Departement de Physiologie, Universite de Montreal, Montreal, Quebec, Canada
    Am J Physiol Renal Physiol 297:F489-98. 2009
  9. ncbi Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus
    Virginie Bernier
    Department of Biochemistry, Groupe de Recherche Universitaire sur le Médicament, Hopital du Sacre Coeur de Montreal, 5400 Boulevard Gouin Ouest, Montreal, Quebec, H4J 1C5 Canada
    J Am Soc Nephrol 17:232-43. 2006
  10. doi Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus
    Reyhan El-Kares
    Department of Pediatrics, Montreal Children s Hospital Research Institute, 4060 Ste Catherine West, Montreal, Quebec, Canada
    Pediatr Nephrol 24:1313-9. 2009

Collaborators

  • Shih Hua Lin
  • P Agre
  • Olivier Devuyst
  • Sei Sasaki
  • Michel Marre
  • L Bankir
  • Michio Kuwahara
  • Marie Francoise Arthus
  • Michele Lonergan
  • Virginie Bernier
  • Alexandre Leduc-Nadeau
  • Pierre Bissonnette
  • Yoann Lussier
  • Reyhan El-Kares
  • Cécile Guyon
  • Michel Bouvier
  • T Mary Fujiwara
  • Pascale Bardoux
  • Alejandro Martinez-Aguayo
  • Eva Riveira-Munoz
  • Nada Jabado
  • Miriam Blumenkrantz
  • Kim Ma
  • Pierre Alain Hueber
  • Paul Goodyer
  • Jean Yves Lapointe
  • Anatoly Tiulpakov
  • Diana Iglesias
  • Rafael Bedoya Perez
  • Andre Laperriere
  • Nicolas Debrand
  • Ali Salahpour
  • Alexandro Zarruk
  • Jean Pierre Morello
  • Remi Brouard
  • Monique Lagacé
  • Nicole Ruel
  • Yves Gallois
  • Helene Martin
  • Nadine Bouby

Detail Information

Publications15

  1. ncbi [Nephrogenic diabetes insipidus]
    Daniel Georges Bichet
    Génétique des maladies rénales, Service de Nephrologie, départements de médecine et de physiologie, Centre de Recherche, Hopital du Sacre Coeur de Montreal, Universite de Montreal, Montreal Quebec, Canada
    Nephrol Ther 2:387-404. 2006
    ....
  2. doi Vasopressin receptor mutations in nephrogenic diabetes insipidus
    Daniel G Bichet
    Genetics of Renal Diseases, Groupe d Etude des Protéines, Membranaires, Montreal, Quebec, Canada
    Semin Nephrol 28:245-51. 2008
    ..Finally, a long-term careful surveillance of all patients with hereditary NDI should be performed to prevent chronic renal failure likely caused by the long-term functional tract obstruction with reflux...
  3. doi Physiopathology of hereditary polyuric states: a molecular view of renal function
    Daniel G Bichet
    Universite de Montreal, Canada
    Swiss Med Wkly 142:w13613. 2012
    ..This genomic information is key to the routine care of patients with congenital polyuria and, as in other genetic diseases, reduces health costs and confers psychological benefits on patients and families...
  4. doi Genetics and diagnosis of central diabetes insipidus
    Daniel G Bichet
    Departments of Medicine and Physiology, University of Montreal, Hôpital du Sacré Cœur de Montréal, Quebec, Canada
    Ann Endocrinol (Paris) 73:117-27. 2012
    ..In addition, simple, inexpensive blood and urine measurements together with clinical characteristics and brain magnetic resonance imaging (MRI) could distinguish between central, nephrogenic and polydipsic cases...
  5. ncbi Hereditary polyuric disorders: new concepts and differential diagnosis
    Daniel G Bichet
    Groupe d Etude des Protéines Membranaires and the Université de Montréal, Research Centre and Nephrology Service, Hopital du Sacre Coeur de Montreal, Montreal, Quebec, Canada
    Semin Nephrol 26:224-33. 2006
    ..The purpose of this article is to increase the general awareness of these congenital NDI patients to prevent severe episodes of dehydration and provide precise molecular diagnosis and treatment...
  6. ncbi Nephrogenic diabetes insipidus
    Daniel G Bichet
    Centre de Recherche, Hôpital du Sacré Couer de Montréal, Montreal, Quebec, Canada
    Adv Chronic Kidney Dis 13:96-104. 2006
    ....
  7. ncbi [Nobel Prize for Chemistry 2003. Water channels and ionic channels]
    Daniel G Bichet
    Groupe d étude des protéines membranaires, Universite de Montreal, Service Néphrologie Génétique, Hopital du Sacre Coeur de Montreal, 5400, boulevard Gouin Ouest, Montreal, Quebec, H4J 1C5, Canada
    Med Sci (Paris) 19:1289-90. 2003
  8. doi Characterization of D150E and G196D aquaporin-2 mutations responsible for nephrogenic diabetes insipidus: importance of a mild phenotype
    Cécile Guyon
    Groupe d étude des protéines membranaires, Departement de Physiologie, Universite de Montreal, Montreal, Quebec, Canada
    Am J Physiol Renal Physiol 297:F489-98. 2009
    ..These results essentially recapitulate the clinical profiles of the family members, showing a typical dominant negative effect when G196D is coinjected with either AQP2-wt or D150E but not between AQP2-wt and D150E mutant...
  9. ncbi Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus
    Virginie Bernier
    Department of Biochemistry, Groupe de Recherche Universitaire sur le Médicament, Hopital du Sacre Coeur de Montreal, 5400 Boulevard Gouin Ouest, Montreal, Quebec, H4J 1C5 Canada
    J Am Soc Nephrol 17:232-43. 2006
    ..This therapeutic approach could be applied to the treatment of several hereditary diseases that result from errors in protein folding and kinesis...
  10. doi Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus
    Reyhan El-Kares
    Department of Pediatrics, Montreal Children s Hospital Research Institute, 4060 Ste Catherine West, Montreal, Quebec, Canada
    Pediatr Nephrol 24:1313-9. 2009
    ..The concurrence of WT and NDI has not been previously reported and may be unrelated. Nevertheless, this case nicely illustrates the sequence of events leading to sporadic Wilms tumor...
  11. pmc New autosomal recessive mutations in aquaporin-2 causing nephrogenic diabetes insipidus through deficient targeting display normal expression in Xenopus oocytes
    Alexandre Leduc-Nadeau
    Groupe d étude des protéines membranaires GÉPROM, Departement de Physiologie, Universite de Montreal, Montreal, Quebec, Canada
    J Physiol 588:2205-18. 2010
    ..The discrepancies in plasma membrane targeting response found in both expression systems stress the need to evaluate such data using mammalian cell systems...
  12. ncbi Two novel aquaporin-2 mutations responsible for congenital nephrogenic diabetes insipidus in Chinese families
    Shih Hua Lin
    Division of Nephrology, Department of Medicine, Tri Service General Hospital, National Defense Medical Center, Montreal, Quebec H4J 1C5, Canada
    J Clin Endocrinol Metab 87:2694-700. 2002
    ..These results provide evidence that the Q57P and G100V mutations in congenital nephrogenic diabetes insipidus are attributable to the misrouting of AQP2...
  13. ncbi Molecular biology of hereditary diabetes insipidus
    T Mary Fujiwara
    Research Center, Hopital du Sacre Coeur de Montreal, 5400 Boulevard Gouin Ouest, Montreal, Quebec, H4J 1C5 Canada
    J Am Soc Nephrol 16:2836-46. 2005
    ..These advances provide diagnostic and clinical tools for physicians who care for these patients...
  14. ncbi Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059
    Virginie Bernier
    Department of Biochemistry, Universite de Montreal, C P 6128 Succursale Centre Ville, Montreal, Quebec, Canada H3C 3J7
    Mol Endocrinol 18:2074-84. 2004
    ..SR49059 treatment significantly improved its maturation and cell surface targeting, indicating that the functional rescue of R137H V2Rs results from the pharmacological chaperone action of the antagonist...
  15. ncbi Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system
    Pascale Bardoux
    INSERM Unité 367, Institut du Fer a Moulin, Paris, France
    Nephrol Dial Transplant 18:497-506. 2003
    ..The present study was thus designed to evaluate whether vasopressin influences UAE in normal rats and humans, whether this effect is V(2)-receptor-dependent, and whether it is mediated by the renin-angiotensin system...